title: Thrombocytopenia in childhood malaria with special reference to P. vivax monoinfection: A study from Bikaner (Northwestern India).
abstract: Thrombocytopenia is commonly seen in Plasmodium vivax malaria, but its prognostic value has not been addressed in children. This prospective study included 676 admitted children of malaria [Plasmodium falciparum (Pf) monoinfection 262, Plasmodium vivax (Pv) monoinfection 380, and mixed (Pf + Pv) infection 34], in which thrombocytopenia (platelet count <150 × 10(3)/mm(3) on admission) was found in 442 (65.38%) children [Pf monoinfection 55.3% (145/262), Pv monoinfection 73.16% (278/380), and mixed infection 55.88% (19/34)]. The association of thrombocytopenia was statistically significant with Pv monoinfection [73.16% (278/380)] in comparison to either Pf monoinfection [55.34% (145/262); odds ratio (OR) = 2.199 (95% confidence interval (CI) 1.577-3.068), p < 0.0001] or mixed infection [55.88% (19/34); OR = 2.152 (95%CI 1.054-4.394), p = 0.032]. In Pv monoinfection, thrombocytopenia was highest in 0-5 years age group and subsequently decreased with advancing age, whereas in Pf monoinfection it was reverse. Severe thrombocytopenia (platelet count <20 × 10(3)/mm(3)) was present in 16.52% (73/442) children [Pv monoinfection 21.58% (60/278) and Pf monoinfection 8.97% (13/145)]. The risk of developing severe thrombocytopenia was also highest in Pv monoinfection [15.79% (60/380)] in comparison to Pf monoinfection [10.59% (13/262); OR = 3.591 (95%CI 1.928-6.690), p < 0.0001]. Bleeding manifestations were associated in 21.27% (94/442) children [Pf monoinfection 9.92% (26/262), Pv monoinfection 16.58% (63/380), and mixed malaria 14.71% (5/34)]. All the children having bleeding manifestations had thrombocytopenia but low platelet counts were not always associated with abnormal bleeding. The association of severe malaria was significantly more among children having Pv monoinfection with platelet counts <20 × 10(3)/mm(3) [OR = 2.569 (95%CI 1.196-5.517), p < 0.014] with specificity of 88.3% and positive predictive value of 85%. Till today, thrombocytopenia is not included in severe malaria criterion described by WHO, but when platelet counts <20 × 103/mm(3), we advocate it to include as one of the severe malaria criteria.
authors.affiliation: Department of Pediatrics, S.P. Medical College, Bikaner, India.
authors.forename: Gajanand Singh
authors.initials: GS
authors.lastname: Tanwar
authors.forename: Punam Chand
authors.initials: PC
authors.lastname: Khatri
authors.forename: Chandra Kumar
authors.initials: CK
authors.lastname: Chahar
authors.forename: Ghanshyam Singh
authors.initials: GS
authors.lastname: Sengar
authors.forename: Abhishek
authors.initials: A
authors.lastname: Kochar
authors.forename: Gayatri
authors.initials: G
authors.lastname: Tanwar
authors.forename: Shaifali
authors.initials: S
authors.lastname: Chahar
authors.forename: Nimish
authors.initials: N
authors.lastname: Khatri
authors.forename: Sheetal
authors.initials: S
authors.lastname: Middha
authors.forename: Jyoti
authors.initials: J
authors.lastname: Acharya
authors.forename: Sanjay Kumar
authors.initials: SK
authors.lastname: Kochar
authors.forename: Deepak
authors.initials: D
authors.lastname: Pakalapati
authors.forename: Shilpi
authors.initials: S
authors.lastname: Garg
authors.forename: Ashis
authors.initials: A
authors.lastname: Das
authors.forename: Dhanpat Kumar
authors.initials: DK
authors.lastname: Kochar
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D006470:Hemorrhage / Q000097:blood / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D007194:India / Q000453:epidemiology; D007223:Infant; D007231:Infant, Newborn; D016778:Malaria, Falciparum / Q000097:blood / Q000150:complications / Q000453:epidemiology; D016780:Malaria, Vivax / Q000097:blood* / Q000150:complications* / Q000453:epidemiology; D008297:Male; D010963:Plasmodium falciparum; D010966:Plasmodium vivax; D010976:Platelet Count; D011446:Prospective Studies; D013921:Thrombocytopenia / Q000097:blood* / Q000453:epidemiology / Q000209:etiology*